Krystal Biotech, Inc. KRYS Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s accumulated depreciation?
- Krystal Biotech, Inc. (KRYS) reported accumulated depreciation of $33.77M in Q1 2026.
- How has Krystal Biotech, Inc.'s accumulated depreciation changed year-over-year?
- Krystal Biotech, Inc.'s accumulated depreciation increased by 39.1% year-over-year, from $24.27M to $33.77M.
- What is the long-term trend for Krystal Biotech, Inc.'s accumulated depreciation?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s accumulated depreciation has grown at a 67.6% compound annual growth rate (CAGR), from $2.37M to $31.28M.